申请人:ARQULE, INC.
公开号:EP2251343A1
公开(公告)日:2010-11-17
In general, the present invention relates to compounds capable of inhibiting p38, methods for inhibiting p38 in vivo or in vitro, and methods for treating conditions associated with p38 activity or cytokine activity.
总的来说,本发明涉及能够抑制 p38 的化合物、体内或体外抑制 p38 的方法,以及治疗与 p38 活性或细胞因子活性相关的疾病的方法。